| 6.27 -0.07 (-1.1%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 7.8 | 1-year : | 9.11 |
| Resists | First : | 6.67 | Second : | 7.8 |
| Pivot price | 5.99 |
|||
| Supports | First : | 5.43 | Second : | 4.65 |
| MAs | MA(5) : | 6.36 |
MA(20) : | 5.77 |
| MA(100) : | 4.68 |
MA(250) : | 3.6 |
|
| MACD | MACD : | 0.2  |
Signal : | 0.2 |
| %K %D | K(14,3) : | 77.4 |
D(3) : | 82.9 |
| RSI | RSI(14): 61.6 |
|||
| 52-week | High : | 6.67 | Low : | 1.78 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SRTS ] has closed below upper band by 29.3%. Bollinger Bands are 1.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.56 - 6.61 | 6.61 - 6.64 |
| Low: | 5.94 - 6 | 6 - 6.04 |
| Close: | 6.19 - 6.27 | 6.27 - 6.33 |
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Thu, 25 Jul 2024
Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024 - StockTitan
Thu, 25 Jul 2024
Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Thu, 25 Jul 2024
Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why - Yahoo Finance
Tue, 23 Jul 2024
Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Tue, 16 Jul 2024
Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Tue, 16 Jul 2024
SRTS - Sensus Healthcare, Inc. Latest Stock News & Market Updates - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 16 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 19 (%) |
| Held by Institutions | 15.2 (%) |
| Shares Short | 410 (K) |
| Shares Short P.Month | 394 (K) |
| EPS | 0.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.57 |
| Profit Margin | 14.6 % |
| Operating Margin | 40.8 % |
| Return on Assets (ttm) | 6.1 % |
| Return on Equity (ttm) | 9.5 % |
| Qtrly Rev. Growth | 155.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.93 |
| EBITDA (p.s.) | 0.34 |
| Qtrly Earnings Growth | 433.2 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | 21.62 |
| PEG Ratio | 0 |
| Price to Book value | 3.99 |
| Price to Sales | 3.24 |
| Price to Cash Flow | -23.74 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|